A Randomized, Double-blind, Placebo-controlled Factorial Study Evaluating the Efficacy and Safety of Co-administration of Olmesartan Medoxomil Plus Amlodipine Compared to Monotherapy in Patients With Mild to Severe Hypertension
Latest Information Update: 19 Feb 2024
At a glance
- Drugs Amlodipine (Primary) ; Olmesartan medoxomil (Primary) ; Olmesartan medoxomil/amlodipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms COACH
- Sponsors Daiichi Sankyo Inc
- 23 Sep 2008 Results were reported in the proceedings of the 23rd Annual Scientific Meeting of the American Society of Hypertension, in May 2008.
- 28 May 2007 Results have been presented.
- 28 May 2007 Status changed from in progress to completed